Travere Therapeutics to Report First Quarter 2024 Financial Results
29 Abril 2024 - 5:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will
report first quarter 2024 financial results on Monday, May 6, 2024,
after the close of the U.S. financial markets. The Company will
host a conference call and webcast to discuss the financial results
and provide a general business update at 4:30 p.m. ET.
The webcast and dial-in information can be
accessed on the Investor page of Travere’s website at
ir.travere.com/events-presentations. Following the live webcast, an
archived version of the call will be available for 30 days on the
Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for
life. We are a biopharmaceutical company that comes together every
day to help patients, families, and caregivers of all backgrounds
as they navigate life with a rare disease. On this path, we know
the need for treatment options is urgent – that is why our global
team works with the rare disease community to identify, develop,
and deliver life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com.
Contact Info
Media:888-969-7879 mediarelations@travere.com |
Investors:888-969-7879 IR@travere.com |
Travere Therapeutics (NASDAQ:TVTX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Travere Therapeutics (NASDAQ:TVTX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024